AstraZeneca#39;s large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company#39;s UK trial fell ill with what was suspected to be a rare spinal inflammatory disorder called transverse myelitis.from Moneycontrol Latest News https://ift.tt/3ocFEUn
Post a Comment
Post a Comment
please do not enter spam link in the comment box